Honorarprofessor Dr. Joachim Mittendorf

1. Mittendorf J.; Hartwig W. Eur. Pat. Appl. 1993, EP 529469 A2:
   Preparation of 2,3-diamino acids from azidomethyldiketopiperazine derivatives.
2. Mittendorf J.; Kunisch F.; Plempel M.; Eur. Pat. Appl. 1993, EP 538691 A1:
   Preparation of aminotetrahydrothiophenecarboxylates as medical fungicides.
#
3. Mittendorf J.; Kunisch F.; Babczinski P.; Plempel M.; Eur. Pat. Appl. 1993, EP 538689 A1:
   Preparation of 3-amino-2,3-dihydro-6H-pyran-2-carboxylates as medical fungicides.
4. Kunisch F.; Mittendorf J,; Plempel M. Eur. Pat. Appl. 1993, EP 538688 A1:
   Preparation and antimycotic activity of substituted tetrahydrofurans.
5. Kunisch F.; Mittendorf J.; Plempel M.; Militzer H.-C. Eur. Pat. Appl. 1993, EP 538692 A1:
   Preparation and antimycotic activity of partially known substituted pyrrolidines.
6. Mittendorf J.; Kunisch F.; Matzke M.; Militzer H.-C.; Endermann R.; Metzger K.; Bremm K.-D.; Plempel M.; Eur. Pat. Appl. 1993, EP 571870 A1:
   Preparation of 1-amino-2-carboxycyclopentanes as antimycotics and antibacterials.
7. Uhr H.; Kunisch F.; Wachtler M.; Kugler M.; Mittendorf J. Ger. Offen. 1995, DE 4403838 A1:
   Preparation of 1,3,2-benzodithiazole 1-oxides as microbicides.
8. Militzer, H.-C.; Matzke M.; Mittendorf J.; Schmidt A.; Ziegelbauer K.; Schoenfeld W. Ger. Offen. 1996, DE 4443890 A1:
   Antimicrobial cyclohex-4-enecarboxylic acids and their preparation.
9. Mittendorf J.; Fey P.; Junge B.; Kaulen J.; van Laak K.; Meier H.; Schohe-Loop R. Eur. Pat. Appl. 1996, EP 716081 A1:
   Highly selective process for the preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives.
10. Fey P.; van Laak K.; Mittendorf J. Ger. Offen. 1996, DE 4446337 A1:
    Preparation of 3-cyanobenzaldehydes.
11. Matzke M.; Militzer H.-C.; Mittendorf J.; Kunisch F.; Schmidt A.; Schoenfeld W.; Ziegelbauer K. Eur. Pat. Appl. 1997, EP 754678 A2:
    Improvement of physiological tolerance of pharmaceutically active beta amino acids.
12. Kunisch F.; Matzke M.; Militzer H.-C.; Mittendorf J.; Babczinski P.; Schmidt A.; Schoenfeld W.; Ziegelbauer K. Ger. Offen. 1997, DE 19604225 A1:
    Condensation of beta amino acids and beta aminocyclohexenoic acids for use as antimicrobial agents.
13. Mittendorf J.; Eur. Pat. Appl. 1997, EP 805145 A1:
    Efficient and highly enantioselective process for the preparation of enantiomerically pure cyclopentane-beta-amino acids.
14. Mittendorf J.; Dressel J.; Matzke M.; Franz J.; Spreyer, P.; Voehringer V.; Schuhmacher J.; Friedl A.; Horvath E.; Mauler F.; de Vry J.; Jork R. Ger. Offen. 1998, DE 19706903 A1:
    Use of agonists of central cannabinoid CB1 receptors in neurodegenerative diseases.
15. Mittendorf J.; Dressel J.; Matzke M.; Keldenich J.; Mohrs K.; Raddatz S.; Franz J.; Spreyer, P.; Voehringer V.; Schuhmacher J.; Rock M. H.; Friedl A.; Horvath E.; Mauler F.; de Vry J.; Jork R. Ger. Offen. 1998, DE 19740785 A1:
    Preparation of arylsulfonamides and related compounds as cannabinoid CB1 and CB2 receptor agonists.
16. Mittendorf J.; Dressel J.; Matzke M.; Keldenich J.; Mauler F.; de Vry J.; Franz J.; Spreyer, P.; Voehringer V.; Schuhmacher J.; Rock M. H.; Horvath E.; Friedl A.; Ger. Offen. 2000, DE 19837627 A1:
    Preparation of alkylsulfonyloxyphenoxyindanylmethanol amino acid esters and related compounds as CB1 and CB2 cannabinoid receptor agonists.
17. Mittendorf J.; Dressel J.; Matzke M.; Keldenich J.; Mauler F.; de Vry J.; Franz J.; Spreyer, P.; Voehringer V.; Schuhmacher J.; Rock M. H.; Horvath E.; Friedl A.; Mohrs K.; Raddatz S.; Jork R. Ger. Offen. 2000, DE 19837638 A1:
    Preparation of aryl trifluorobutylsulfonates as CB1 receptor antagonists.
18. Mittendorf J.; Henning R.; Raddatz S.; Schlemmer K.-H., Hiraoka M.; Kadono H.; Mogi M.; Moriwaki T.; Murata T.; Sakakibara S.; Shimada M.; Yoshida N.; Yoshino T. PCT Int. Appl. 2000, WO2000020401 A1:
    Preparation of bis-benzimidazoles as tryptase inhibitors.
19. Haerter M.; Albrecht B.; Gerisch M.; Handke G.; Huetter J.; Jensen A.; Krahn T.; Mittendorf J.; Oehme F.; Schlemmer K.-H.; Steinhagen H. PCT Int. Appl. 2002, WO2002006247 A1:
    Preparation of fused amidoalkyluracils as poly(ADP-ribose) synthetase inhibitors.
20. Feurer A.; Bennabi S.; Heckroth H.; Schirok H.; Mittendorf J.; Kast R.; Stasch J.-P.; Gnoth M. J.; Muenter K.; Lang D.; Figueroa Perez S.; Ehmke, H. PCT Int. Appl. 2004, WO20040039796 A1:
    Preparation of phenylaminopyrimidines as Rho-Kinase II inhibitors for the treatment of cardiovascular diseases.
21. Bennabi S.; Heckroth H.; Schirok H.; Mittendorf J.; Kast R.; Stasch J.-P.; Gnoth M. J.; Muenter K.; Lang D.; Figueroa Perez S.; Bauser M.; Feurer A.; Ehmke, H. PCT Int. Appl. 2005, WO2005058891 A1:
    Preparation of pyrrolopyridinyloxyphenylamides and related compounds as cardiovascular agents.
22. Schirok H.; Radtke M.; Mittendorf J.; Kast R.; Stasch J.-P.; Gnoth M. J.; Muenter K.; Lang D.; Figueroa Perez S.; Thutewohl M.; Bennabi S.; Ehmke, H. PCT Int. Appl. 2005, WO2005007790 A1:
    Preparation of heteroaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitors.
23. Schirok H.; Stasch J.-P.; Kast R.; Muenter K.; Gnoth M. J.; Figueroa Perez S.; Thutewohl M.; Bennabi S.; Radtke M.; Lang D.; Mittendorf J.; Ehmke, H. PCT Int. Appl. 2005, WO2005108397 A1:
    Preparation of substituted phenylaminopyrimidines for use as cardiovascular agents.
24. Schirok H.; Stasch J.-P.; Kast R.; .; Figueroa Perez S.; Muenter K.; Gnoth M. J.; Radtke M.; Lang D.; Mittendorf J. Ger. Offen. 2006, DE 102004060752 A1:
    Preparation of 4-phenoxy-7-azaindoles as rho kinase II inhibitors.
25. Schirok H.; Griebenow N.; Fuerstner C.; Mittendorf J.; Stasch J.-P.; Wunder F.; Schlemmer K.-H.; Heitmeier S.; Stoll F. PCT Int. Appl. 2007, WO2007124854 A1:
    Fused pyrazole derivatives as cardiovascular agents, their preparation, pharmaceutical compositions, and use in therapy.
26. Fuerstner C.; Schirok H.; Griebenow N.; Mittendorf J.; Stasch J.-P.; Wunder F.; PCT Int. Appl. 2007, WO2007128454 A1:
    Preparation of 3-tetrazolylpyrazolopyridines as cardiovascular agents.